Record ID | marc_western_washington_univ/wwu_bibs.mrc_revrev.mrc:672472893:1015 |
Source | Western Washington University |
Download Link | /show-records/marc_western_washington_univ/wwu_bibs.mrc_revrev.mrc:672472893:1015?format=raw |
LEADER: 01015cam 2200265Ia 4500
001 ocm41277696
003 OCoLC
005 19991209164036.0
008 990429s1998 nyua 000 0 eng d
040 $aLVC$cLVC$dUMC$dXFF
049 $aXFFA
090 $aHD9999.B444$bA44 1998
100 1 $aBinder, Gordon M.,$d1935-
245 10 $aAmgen /$cGordon M. Binder.
260 $aNew York :$bNewcomen Society of the United States,$c1998.
300 $a27 p. :$bill. ;$c23 cm.
440 0 $aNewcomen publication ;$vno. 1518
500 $a"This address, dealing with the history of AMGEN{reg}, was delivered at a '1998 Los Angeles Meeting' of the Newcomen Society of the United States held in Los Angeles, when Gordon M. Binder was guest of honor and speaker on April 27th, 1998."--P. [1].
650 0 $aBiotechnology industries$zUnited States.
710 2 $aAmgen Inc.
710 2 $aNewcomen Society of the United States.
907 $a.b18813690$bmulti$c-
902 $a070705
998 $b1$c991210$dm$ea$f-$g0
902 $ass